Cytotoxic Constituents from Podocarpus fasciculus
A new diterpene, 16-hydroxy communic acid (1), along with thirty one known compounds including five norditerpenes (2—6), twenty two flavonoids containing four biflavonoids (7—10), nine monoflavonoids (11—19) and nine flavanoid glycosides (20—28), as well as four phenolic constituents (29—32) were is...
        Saved in:
      
    
          | Published in | Chemical & Pharmaceutical Bulletin Vol. 56; no. 4; pp. 585 - 588 | 
|---|---|
| Main Authors | , , , , , , | 
| Format | Journal Article | 
| Language | English | 
| Published | 
        TOKYO
          The Pharmaceutical Society of Japan
    
        01.04.2008
     Pharmaceutical Society of Japan Pharmaceutical Soc Japan Japan Science and Technology Agency  | 
| Subjects | |
| Online Access | Get full text | 
| ISSN | 0009-2363 1347-5223 1347-5223  | 
| DOI | 10.1248/cpb.56.585 | 
Cover
| Summary: | A new diterpene, 16-hydroxy communic acid (1), along with thirty one known compounds including five norditerpenes (2—6), twenty two flavonoids containing four biflavonoids (7—10), nine monoflavonoids (11—19) and nine flavanoid glycosides (20—28), as well as four phenolic constituents (29—32) were isolated from the 95% ethanolic extract of Podocarpus fasciculus. The structure of 1 was elucidated using spectral methods. Of these isolates, nagilactone C (2) showed the most significant inhibitory effects against DLD cells (human colon carcinoma) (ED50=2.57 μg/ml) and compounds 7, 8, 10, 11, and 12 had moderate cytotoxic activity against human KB (human oral epithelium carcinoma), Hela (human cervical carcinoma), Hepa (human hepatoma), DLD (colon carcinoma), and A-549 (human lung carcinoma) tumor cell lines. Preliminary structure–activity relationship studies of the isolated diterpenoids and biflavonoids are discussed. | 
|---|---|
| Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 content type line 23  | 
| ISSN: | 0009-2363 1347-5223 1347-5223  | 
| DOI: | 10.1248/cpb.56.585 |